Shares of Cencora Inc. COR shed 1.64% to $254.21 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.50% to 6,040.53 and ...

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at where Cencora, Inc. (NYSE:COR) stands against the other stocks Jim Cramer ...

In this article, we are going to take a look at where Cencora, Inc. (NYSE:COR) stands against the other stocks Jim Cramer recently talked about. Jim Cramer, the host of Mad Money, has been ...

The founding members of the consortium are AlignRx, Cardinal Health, Cencora, Epic, McKesson and Pharmacy First. For more information about the consortium and its activities, please visit ncpa.org ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Cencora (COR) reports results for the quarter ended December 2024. While this widely-known consensus outlook is ...

Cencora COR has outperformed the market over the past 10 years by 6.19% on an annualized basis producing an average annual return of 17.58%. Currently, Cencora has a market capitalization of $49. ...

Wells Fargo analyst Stephen Baxter raised the firm’s price target on Cencora (COR) to $251 from $237 and keeps an Equal Weight rating on the shares following new guidance. The firm notes Cencora ...

Wells Fargo analyst Stephen Baxter maintained a Hold rating on Cencora (COR – Research Report) yesterday and set a price target of $251.00. The company’s shares closed yesterday at $255.10.

Cencora, Inc. (NYSE:COR – Get Free Report)’s share price reached a new 52-week high on Monday after JPMorgan Chase & Co. raised their price target on the stock from $289.00 to $301.00.